LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

• Published in: Journal of biomedical science Vol. 30; no. 1; pp. 1 - 20
• Main Authors: Chen, Yi-Ling, Liu, Yi-Nan, Lin, Yen-Ting, Tsai, Meng-Feng, Wu, Shang-Gin, Chang, Tzu-Hua, Hsu, Chia-Lang, Wu, Huey-Dong, Shih, Jin-Yuan
• Format: Journal Article
• Language: English
• Published: Basel BioMed Central Ltd 19.09.2023; BioMed Central; BMC
• Subjects: Adenocarcinoma; Analysis; Antibodies; Cell growth; Cell migration; Chromatin; Cloning; Colorectal cancer; Cytoskeleton; Development and progression; DNA-binding protein; Filaments; Fluorescence in situ hybridization; Gene expression; Gene sequencing; Genetic transcription; High mobility group proteins; High-throughput screening; Immunoprecipitation; In vivo methods and tests; Long non-coding RNA; Lung cancer; Malignancy; Mass spectrometry; Mass spectroscopy; Metastases; Metastasis; MicroRNAs; Neurotensin; Non-coding RNA; Polymerase chain reaction; Protein binding; Proteins; Regulatory mechanisms (biology); Reverse transcription; Ribonucleic acid; RNA; RNA polymerase; RNA sequencing; Scientific equipment and supplies industry; Sequestering; SLCO4A1-AS1; Western blotting; United States; United States > US; Taiwan
• ISSN: 1423-0127; 1021-7770; 1423-0127
• DOI: 10.1186/s12929-023-00973-9

Background Metastasis is a multistep process involving the migration and invasion of cancer cells and is a hallmark of cancer malignancy. Long non-coding RNAs (lncRNAs) play critical roles in the regulation of metastasis. This study aims to elucidate the role of the lncRNA solute carrier organic anion transporter family member 4A1-antisense 1 (SLCO4A1-AS1) in metastasis and its underlying regulatory mechanisms. Methods A comprehensive analysis of the Gene Expression Omnibus (GEO) database were used to identify metastasis-associated lncRNAs. Transwell migration and invasion assays, and a tail vein-injection mouse model were used to assess the migration and invasion of cancer cells in vitro and in vivo, respectively. High-throughput screening methods, including MASS Spectrometry and RNA sequencing (RNA-seq), were used to identify the downstream targets of SLCO4A1-AS1. Reverse transcription quantitative polymerase chain reaction (RT-qPCR), western blotting, RNA pull-down, RNA immunoprecipitation (RIP), fluorescence in situ hybridization (FISH), and chromatin immunoprecipitation (ChIp) assays were conducted to identify and validate the underlying regulatory mechanisms of SLCO4A1-AS1. Results SLCO4A1-AS1 reduced cancer cell migration and invasion by disrupting cytoskeleton filaments, and was associated with longer overall survival in patients with lung adenocarcinoma. SLCO4A1-AS1 directly interacted with the DNA-binding protein, TOX High Mobility Group Box Family Member 4 (TOX4), to inhibit TOX4-induced migration and invasion. Furthermore, RNA-seq revealed that neurotensin receptor 1 (NTSR1) is a novel and convergent downstream target of SLCO4A1-AS1 and TOX4. Mechanistically, SLCO4A1-AS1 functions as a decoy of TOX4 by interrupting its interaction with the NTSR1 promoter and preventing NTSR1 transcription. Functionally, NTSR1 promotes cancer cell migration and invasion through cytoskeletal remodeling, and knockdown of NTSR1 significantly inhibits TOX4-induced migration and invasion. Conclusion These findings demonstrated that SLCO4A1-AS1 antagonizes TOX4/NTSR1 signaling, underscoring its pivotal role in lung cancer cell migration and invasion. These findings hold promise for the development of novel therapeutic strategies targeting the SLCO4A1-AS1/TOX4/NTSR1 axis as a potential avenue for effective therapeutic intervention in lung cancer. Keywords: SLCO4A1-AS1, Long non-coding RNA, Cytoskeleton, Metastasis, Lung cancer